Tony Hooper, who spent 7 years at Amgen as the executive vice president of Global Commercial Operations, was just added to Mannkind's Board of Directors. Yes, he isn't at Amgen anymore but these types of placements happen all the time on company's boards.
“Tony will be a terrific addition to our board of directors,” said Kent Kresa, Chairman of the Board of MannKind Corporation. “His commercial operations experience and his deep knowledge of the pharmaceutical industry will be invaluable to MannKind as we look to grow our company for the future.”
It wouldn't shock me if this is the first step in their due dilligence.